ID   KC1D_HUMAN              Reviewed;         409 AA.
AC   P48730-2;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-JAN-2003, sequence version 2.
DT   12-OCT-2022, entry version 218.
DE   RecName: Full=Isoform 2 of Casein kinase I isoform delta;
DE            Short=CKI-delta;
DE            Short=CKId;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:14761950, ECO:0000269|PubMed:17562708, ECO:0000269|PubMed:20041275, ECO:0000269|PubMed:20637175, ECO:0000269|PubMed:21422228, ECO:0000269|PubMed:23636092};
DE   AltName: Full=Tau-protein kinase CSNK1D;
DE            EC=2.7.11.26 {ECO:0000269|PubMed:14761950, ECO:0000269|PubMed:16618118, ECO:0000269|PubMed:17562708};
GN   Name=CSNK1D; Synonyms=HCKID;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8786104; DOI=10.1006/geno.1996.0091;
RA   Kusuda J., Hidari N., Hidari M., Hashimoto K.;
RT   "Sequence analysis of the cDNA for the human casein kinase I delta (CSNK1D)
RT   gene and its chromosomal localization.";
RL   Genomics 32:140-143(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Hematopoietic stem cell;
RX   PubMed=15070676; DOI=10.1182/blood-2003-08-2768;
RA   Okamura A., Iwata N., Nagata A., Tamekane A., Shimoyama M., Gomyo H.,
RA   Yakushijin K., Urahama N., Hamaguchi M., Fukui C., Chihara K., Ito M.,
RA   Matsui T.;
RT   "Involvement of casein kinase Iepsilon in cytokine-induced granulocytic
RT   differentiation.";
RL   Blood 103:2997-3004(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ACTIVITY REGULATION, AND AUTOPHOSPHORYLATION.
RX   PubMed=9632646; DOI=10.1074/jbc.273.26.15980;
RA   Rivers A., Gietzen K.F., Vielhaber E., Virshup D.M.;
RT   "Regulation of casein kinase I epsilon and casein kinase I delta by an in
RT   vivo futile phosphorylation cycle.";
RL   J. Biol. Chem. 273:15980-15984(1998).
RN   [7]
RP   FUNCTION AS TP53 KINASE, AND CATALYTIC ACTIVITY.
RX   PubMed=10606744; DOI=10.1016/s0014-5793(99)01647-6;
RA   Dumaz N., Milne D.M., Meek D.W.;
RT   "Protein kinase CK1 is a p53-threonine 18 kinase which requires prior
RT   phosphorylation of serine 15.";
RL   FEBS Lett. 463:312-316(1999).
RN   [8]
RP   INTERACTION WITH TUBULINS, AND SUBCELLULAR LOCATION.
RX   PubMed=10826492; DOI=10.1078/s0171-9335(04)70027-8;
RA   Behrend L., Stoeter M., Kurth M., Rutter G., Heukeshoven J., Deppert W.,
RA   Knippschild U.;
RT   "Interaction of casein kinase 1 delta (CK1delta) with post-Golgi
RT   structures, microtubules and the spindle apparatus.";
RL   Eur. J. Cell Biol. 79:240-251(2000).
RN   [9]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-38 AND THR-176.
RX   PubMed=11161704; DOI=10.1006/excr.2000.5100;
RA   Milne D.M., Looby P., Meek D.W.;
RT   "Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is
RT   essential for its normal subcellular localization.";
RL   Exp. Cell Res. 263:43-54(2001).
RN   [10]
RP   INTERACTION WITH PER1 AND PER2.
RX   PubMed=11165242; DOI=10.1016/s0014-5793(00)02434-0;
RA   Camacho F., Cilio M., Guo Y., Virshup D.M., Patel K., Khorkova O.,
RA   Styren S., Morse B., Yao Z., Keesler G.A.;
RT   "Human casein kinase Idelta phosphorylation of human circadian clock
RT   proteins period 1 and 2.";
RL   FEBS Lett. 489:159-165(2001).
RN   [11]
RP   FUNCTION AS CONNEXIN-43/GJA1 KINASE, INTERACTION WITH CONNEXIN-43/GJA1, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=12270943; DOI=10.1074/jbc.m209427200;
RA   Cooper C.D., Lampe P.D.;
RT   "Casein kinase 1 regulates connexin-43 gap junction assembly.";
RL   J. Biol. Chem. 277:44962-44968(2002).
RN   [12]
RP   INTERACTION WITH AKAP9/AKAP450, AND SUBCELLULAR LOCATION.
RX   PubMed=12270714; DOI=10.1016/s0022-2836(02)00857-4;
RA   Sillibourne J.E., Milne D.M., Takahashi M., Ono Y., Meek D.W.;
RT   "Centrosomal anchoring of the protein kinase CK1delta mediated by
RT   attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450.";
RL   J. Mol. Biol. 322:785-797(2002).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [14]
RP   FUNCTION AS MAPT/TAU KINASE, ACTIVITY REGULATION, INTERACTION WITH
RP   MAPT/TAU, AND CATALYTIC ACTIVITY.
RX   PubMed=14761950; DOI=10.1074/jbc.m314116200;
RA   Li G., Yin H., Kuret J.;
RT   "Casein kinase 1 delta phosphorylates tau and disrupts its binding to
RT   microtubules.";
RL   J. Biol. Chem. 279:15938-15945(2004).
RN   [15]
RP   FUNCTION IN MITOTIC SPINDLE FORMATION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, DEVELOPMENTAL STAGE, AND ACTIVITY REGULATION.
RX   PubMed=16027726; DOI=10.1038/sj.onc.1208941;
RA   Stoeter M., Bamberger A.-M., Aslan B., Kurth M., Speidel D., Loening T.,
RA   Frank H.-G., Kaufmann P., Loehler J., Henne-Bruns D., Deppert W.,
RA   Knippschild U.;
RT   "Inhibition of casein kinase I delta alters mitotic spindle formation and
RT   induces apoptosis in trophoblast cells.";
RL   Oncogene 24:7964-7975(2005).
RN   [16]
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH DBNDD2.
RX   PubMed=16618118; DOI=10.1021/bi052354e;
RA   Yin H., Laguna K.A., Li G., Kuret J.;
RT   "Dysbindin structural homologue CK1BP is an isoform-selective binding
RT   partner of human casein kinase-1.";
RL   Biochemistry 45:5297-5308(2006).
RN   [17]
RP   FUNCTION AS PKD2 KINASE, AND CATALYTIC ACTIVITY.
RX   PubMed=17962809; DOI=10.1038/sj.emboj.7601891;
RA   von Blume J., Knippschild U., Dequiedt F., Giamas G., Beck A., Auer A.,
RA   Van Lint J., Adler G., Seufferlein T.;
RT   "Phosphorylation at Ser244 by CK1 determines nuclear localization and
RT   substrate targeting of PKD2.";
RL   EMBO J. 26:4619-4633(2007).
RN   [18]
RP   FUNCTION AS MAPT/TAU KINASE, AND CATALYTIC ACTIVITY.
RX   PubMed=17562708; DOI=10.1074/jbc.m703269200;
RA   Hanger D.P., Byers H.L., Wray S., Leung K.-Y., Saxton M.J., Seereeram A.,
RA   Reynolds C.H., Ward M.A., Anderton B.H.;
RT   "Novel phosphorylation sites in tau from Alzheimer brain support a role for
RT   casein kinase 1 in disease pathogenesis.";
RL   J. Biol. Chem. 282:23645-23654(2007).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331 AND SER-384, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   ACTIVITY REGULATION, AND CATALYTIC ACTIVITY.
RX   PubMed=19591487; DOI=10.1021/jm9005127;
RA   Peifer C., Abadleh M., Bischof J., Hauser D., Schattel V., Hirner H.,
RA   Knippschild U., Laufer S.;
RT   "3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of
RT   p38alpha mitogen activated protein kinase and casein kinase 1delta.";
RL   J. Med. Chem. 52:7618-7630(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [24]
RP   FUNCTION AS TOP2A KINASE, ACTIVITY REGULATION, AND CATALYTIC ACTIVITY.
RX   PubMed=19043076; DOI=10.1093/nar/gkn934;
RA   Grozav A.G., Chikamori K., Kozuki T., Grabowski D.R., Bukowski R.M.,
RA   Willard B., Kinter M., Andersen A.H., Ganapathi R., Ganapathi M.K.;
RT   "Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at
RT   serine-1106 and modulates DNA cleavage activity.";
RL   Nucleic Acids Res. 37:382-392(2009).
RN   [25]
RP   RETRACTED PAPER.
RX   PubMed=19339517; DOI=10.1093/nar/gkp136;
RA   Giamas G., Castellano L., Feng Q., Knippschild U., Jacob J., Thomas R.S.,
RA   Coombes R.C., Smith C.L., Jiao L.R., Stebbing J.;
RT   "CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an
RT   estrogen-dependent manner and regulates ERalpha-AIB1 interactions.";
RL   Nucleic Acids Res. 37:3110-3123(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [27]
RP   FUNCTION AS DCK KINASE, AND CATALYTIC ACTIVITY.
RX   PubMed=20637175; DOI=10.1016/j.abb.2010.07.009;
RA   Smal C., Vertommen D., Amsailale R., Arts A., Degand H., Morsomme P.,
RA   Rider M.H., Neste E.V., Bontemps F.;
RT   "Casein kinase 1delta activates human recombinant deoxycytidine kinase by
RT   Ser-74 phosphorylation, but is not involved in the in vivo regulation of
RT   its activity.";
RL   Arch. Biochem. Biophys. 502:44-52(2010).
RN   [28]
RP   FUNCTION AS P53/TP53 KINASE, GENE FAMILY, AND CATALYTIC ACTIVITY.
RX   PubMed=20041275; DOI=10.1007/s00018-009-0236-7;
RA   Venerando A., Marin O., Cozza G., Bustos V.H., Sarno S., Pinna L.A.;
RT   "Isoform specific phosphorylation of p53 by protein kinase CK1.";
RL   Cell. Mol. Life Sci. 67:1105-1118(2010).
RN   [29]
RP   FUNCTION AS YAP1 KINASE, AND CATALYTIC ACTIVITY.
RX   PubMed=20048001; DOI=10.1101/gad.1843810;
RA   Zhao B., Li L., Tumaneng K., Wang C.-Y., Guan K.-L.;
RT   "A coordinated phosphorylation by Lats and CK1 regulates YAP stability
RT   through SCF(beta-TRCP).";
RL   Genes Dev. 24:72-85(2010).
RN   [30]
RP   FUNCTION AS HIF1A KINASE, AND CATALYTIC ACTIVITY.
RX   PubMed=20699359; DOI=10.1242/jcs.068122;
RA   Kalousi A., Mylonis I., Politou A.S., Chachami G., Paraskeva E., Simos G.;
RT   "Casein kinase 1 regulates human hypoxia-inducible factor HIF-1.";
RL   J. Cell Sci. 123:2976-2986(2010).
RN   [31]
RP   FUNCTION IN CIRCADIAN RHYTHMS, AND ACTIVITY REGULATION.
RX   PubMed=20696890; DOI=10.1073/pnas.1005101107;
RA   Meng Q.-J., Maywood E.S., Bechtold D.A., Lu W.-Q., Li J., Gibbs J.E.,
RA   Dupre S.M., Chesham J.E., Rajamohan F., Knafels J., Sneed B.,
RA   Zawadzke L.E., Ohren J.F., Walton K.M., Wager T.T., Hastings M.H.,
RA   Loudon A.S.I.;
RT   "Entrainment of disrupted circadian behavior through inhibition of casein
RT   kinase 1 (CK1) enzymes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:15240-15245(2010).
RN   [32]
RP   FUNCTION IN CIRCADIAN RHYTHMS, AND ACTIVITY REGULATION.
RX   PubMed=20407760; DOI=10.1007/s00213-010-1860-5;
RA   Sprouse J., Reynolds L., Kleiman R., Tate B., Swanson T.A., Pickard G.E.;
RT   "Chronic treatment with a selective inhibitor of casein kinase I
RT   delta/epsilon yields cumulative phase delays in circadian rhythms.";
RL   Psychopharmacology 210:569-576(2010).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [35]
RP   FUNCTION AS EIF6 KINASE, ACTIVITY REGULATION, AND CATALYTIC ACTIVITY.
RX   PubMed=21084295; DOI=10.1074/jbc.m110.188565;
RA   Biswas A., Mukherjee S., Das S., Shields D., Chow C.W., Maitra U.;
RT   "Opposing action of casein kinase 1 and calcineurin in nucleo-cytoplasmic
RT   shuttling of mammalian translation initiation factor eIF6.";
RL   J. Biol. Chem. 286:3129-3138(2011).
RN   [36]
RP   FUNCTION AS DVL2 AND DVL3 KINASE, ACTIVITY REGULATION, SUBCELLULAR
RP   LOCATION, AND CATALYTIC ACTIVITY.
RX   PubMed=21422228; DOI=10.1083/jcb.201011111;
RA   Greer Y.E., Rubin J.S.;
RT   "Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-
RT   dependent neurite outgrowth.";
RL   J. Cell Biol. 192:993-1004(2011).
RN   [37]
RP   ACTIVITY REGULATION, AND AUTOPHOSPHORYLATION.
RX   PubMed=21258417; DOI=10.1038/onc.2010.627;
RA   Cheong J.K., Nguyen T.H., Wang H., Tan P., Voorhoeve P.M., Lee S.H.,
RA   Virshup D.M.;
RT   "IC261 induces cell cycle arrest and apoptosis of human cancer cells via
RT   CK1delta/epsilon and Wnt/beta-catenin independent inhibition of mitotic
RT   spindle formation.";
RL   Oncogene 30:2558-2569(2011).
RN   [38]
RP   REVIEW ON CIRCADIAN RHYTHMS, AND GENE FAMILY.
RX   PubMed=21145983; DOI=10.1016/j.biocel.2010.12.004;
RA   Cheong J.K., Virshup D.M.;
RT   "Casein kinase 1: Complexity in the family.";
RL   Int. J. Biochem. Cell Biol. 43:465-469(2011).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328; SER-331; SER-382;
RP   SER-384 AND SER-407, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [40]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [41]
RP   INTERACTION WITH DDX3X.
RX   PubMed=29222110; DOI=10.1242/jcs.207316;
RA   Dolde C., Bischof J., Grueter S., Montada A., Halekotte J., Peifer C.,
RA   Kalbacher H., Baumann U., Knippschild U., Suter B.;
RT   "A CK1 FRET biosensor reveals that DDX3X is an essential activator of
RT   CK1epsilon.";
RL   J. Cell Sci. 131:0-0(2018).
RN   [42]
RP   RETRACTION NOTICE OF PUBMED:19339517.
RX   PubMed=34718754; DOI=10.1093/nar/gkab845;
RA   Giamas G., Castellano L., Feng Q., Knippschild U., Jacob J., Thomas R.S.,
RA   Coombes R.C., Smith C.L., Jiao L.R., Stebbing J.;
RT   "Retraction of 'CK1delta modulates the transcriptional activity of ERalpha
RT   via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1
RT   interactions'.";
RL   Nucleic Acids Res. 49:12006-12006(2021).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   PubMed=9761932; DOI=10.1107/s0907444997011724;
RA   Longenecker K.L., Roach P.J., Hurley T.D.;
RT   "Crystallographic studies of casein kinase I delta toward a structural
RT   understanding of auto-inhibition.";
RL   Acta Crystallogr. D 54:473-475(1998).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 1-294 IN COMPLEX WITH INHIBITOR,
RP   AND SUBUNIT.
RX   PubMed=22168824; DOI=10.1021/jm201387s;
RA   Long A., Zhao H., Huang X.;
RT   "Structural basis for the interaction between casein kinase 1 delta and a
RT   potent and selective inhibitor.";
RL   J. Med. Chem. 55:956-960(2012).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) OF 1-294 IN COMPLEX WITH INHIBITOR,
RP   AND SUBUNIT.
RX   PubMed=23106386; DOI=10.1021/jm301336n;
RA   Long A.M., Zhao H., Huang X.;
RT   "Structural basis for the potent and selective inhibition of casein kinase
RT   1 epsilon.";
RL   J. Med. Chem. 55:10307-10311(2012).
RN   [46]
RP   VARIANT FASPS2 ALA-44.
RX   PubMed=15800623; DOI=10.1038/nature03453;
RA   Xu Y., Padiath Q.S., Shapiro R.E., Jones C.R., Wu S.C., Saigoh N.,
RA   Saigoh K., Ptacek L.J., Fu Y.H.;
RT   "Functional consequences of a CKIdelta mutation causing familial advanced
RT   sleep phase syndrome.";
RL   Nature 434:640-644(2005).
RN   [47]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-97.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [48]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-97 AND ALA-401.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [49]
RP   VARIANTS FASPS2 ALA-44 AND ARG-46, CHARACTERIZATION OF VARIANTS FASPS2
RP   ALA-44 AND ARG-46, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=23636092; DOI=10.1126/scitranslmed.3005784;
RA   Brennan K.C., Bates E.A., Shapiro R.E., Zyuzin J., Hallows W.C., Huang Y.,
RA   Lee H.Y., Jones C.R., Fu Y.H., Charles A.C., Ptacek L.J.;
RT   "Casein kinase idelta mutations in familial migraine and advanced phase.";
RL   Sci. Transl. Med. 5:183ra56-183ra56(2013).
CC   -!- INTERACTION:
CC       P48730-2; P05067: APP; NbExp=3; IntAct=EBI-9087876, EBI-77613;
CC       P48730-2; Q92624: APPBP2; NbExp=3; IntAct=EBI-9087876, EBI-743771;
CC       P48730-2; Q96GW7: BCAN; NbExp=3; IntAct=EBI-9087876, EBI-2690445;
CC       P48730-2; Q8IU99: CALHM1; NbExp=3; IntAct=EBI-9087876, EBI-1790341;
CC       P48730-2; Q03135: CAV1; NbExp=3; IntAct=EBI-9087876, EBI-603614;
CC       P48730-2; P45973: CBX5; NbExp=3; IntAct=EBI-9087876, EBI-78219;
CC       P48730-2; P06850: CRH; NbExp=3; IntAct=EBI-9087876, EBI-3870390;
CC       P48730-2; Q01658: DR1; NbExp=3; IntAct=EBI-9087876, EBI-750300;
CC       P48730-2; Q9BS26: ERP44; NbExp=3; IntAct=EBI-9087876, EBI-541644;
CC       P48730-2; P35637: FUS; NbExp=3; IntAct=EBI-9087876, EBI-400434;
CC       P48730-2; P17302: GJA1; NbExp=3; IntAct=EBI-9087876, EBI-1103439;
CC       P48730-2; Q9H8Y8: GORASP2; NbExp=3; IntAct=EBI-9087876, EBI-739467;
CC       P48730-2; P25098: GRK2; NbExp=3; IntAct=EBI-9087876, EBI-3904795;
CC       P48730-2; Q00403: GTF2B; NbExp=3; IntAct=EBI-9087876, EBI-389564;
CC       P48730-2; Q9Y5Q9: GTF3C3; NbExp=3; IntAct=EBI-9087876, EBI-1054873;
CC       P48730-2; P42858: HTT; NbExp=15; IntAct=EBI-9087876, EBI-466029;
CC       P48730-2; Q14114-3: LRP8; NbExp=3; IntAct=EBI-9087876, EBI-25832196;
CC       P48730-2; Q5S007: LRRK2; NbExp=3; IntAct=EBI-9087876, EBI-5323863;
CC       P48730-2; Q16539: MAPK14; NbExp=3; IntAct=EBI-9087876, EBI-73946;
CC       P48730-2; Q96L34: MARK4; NbExp=3; IntAct=EBI-9087876, EBI-302319;
CC       P48730-2; P35240-4: NF2; NbExp=3; IntAct=EBI-9087876, EBI-1014514;
CC       P48730-2; Q6ZW49: PAXIP1; NbExp=3; IntAct=EBI-9087876, EBI-743225;
CC       P48730-2; O14494: PLPP1; NbExp=3; IntAct=EBI-9087876, EBI-2865290;
CC       P48730-2; D3DTS7: PMP22; NbExp=3; IntAct=EBI-9087876, EBI-25882629;
CC       P48730-2; P17612: PRKACA; NbExp=3; IntAct=EBI-9087876, EBI-476586;
CC       P48730-2; P07602: PSAP; NbExp=3; IntAct=EBI-9087876, EBI-716699;
CC       P48730-2; P54725: RAD23A; NbExp=3; IntAct=EBI-9087876, EBI-746453;
CC       P48730-2; P04271: S100B; NbExp=3; IntAct=EBI-9087876, EBI-458391;
CC       P48730-2; Q8WTV0: SCARB1; NbExp=3; IntAct=EBI-9087876, EBI-78657;
CC       P48730-2; P50454: SERPINH1; NbExp=3; IntAct=EBI-9087876, EBI-350723;
CC       P48730-2; Q8IUQ4-2: SIAH1; NbExp=3; IntAct=EBI-9087876, EBI-11522811;
CC       P48730-2; P84022: SMAD3; NbExp=3; IntAct=EBI-9087876, EBI-347161;
CC       P48730-2; P37840: SNCA; NbExp=3; IntAct=EBI-9087876, EBI-985879;
CC       P48730-2; P00441: SOD1; NbExp=3; IntAct=EBI-9087876, EBI-990792;
CC       P48730-2; Q6NUL7: SPTLC1; NbExp=3; IntAct=EBI-9087876, EBI-25912847;
CC       P48730-2; Q13148: TARDBP; NbExp=6; IntAct=EBI-9087876, EBI-372899;
CC       P48730-2; P37173: TGFBR2; NbExp=3; IntAct=EBI-9087876, EBI-296151;
CC       P48730-2; Q9NRS4: TMPRSS4; NbExp=3; IntAct=EBI-9087876, EBI-10313040;
CC       P48730-2; Q9BVJ6: UTP14A; NbExp=3; IntAct=EBI-9087876, EBI-473284;
CC       P48730-2; Q9UBQ0-2: VPS29; NbExp=3; IntAct=EBI-9087876, EBI-11141397;
CC       P48730-2; Q8IUH5: ZDHHC17; NbExp=3; IntAct=EBI-9087876, EBI-524753;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P48730-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48730-2; Sequence=VSP_010253;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS11806.1; -.
DR   RefSeq; NP_620693.1; NM_139062.2.
DR   ProteomicsDB; 55931; -.
DR   Ensembl; ENST00000392334.6; ENSP00000376146.2; ENSG00000141551.15.
DR   Proteomes; UP000005640; Chromosome 17.
PE   1: Evidence at protein level;
SQ   SEQUENCE   409 AA;  46832 MW;  970B55B1AF6B56DD CRC64;
     MELRVGNRYR LGRKIGSGSF GDIYLGTDIA AGEEVAIKLE CVKTKHPQLH IESKIYKMMQ
     GGVGIPTIRW CGAEGDYNVM VMELLGPSLE DLFNFCSRKF SLKTVLLLAD QMISRIEYIH
     SKNFIHRDVK PDNFLMGLGK KGNLVYIIDF GLAKKYRDAR THQHIPYREN KNLTGTARYA
     SINTHLGIEQ SRRDDLESLG YVLMYFNLGS LPWQGLKAAT KRQKYERISE KKMSTPIEVL
     CKGYPSEFAT YLNFCRSLRF DDKPDYSYLR QLFRNLFHRQ GFSYDYVFDW NMLKFGASRA
     ADDAERERRD REERLRHSRN PATRGLPSTA SGRLRGTQEV APPTPLTPTS HTANTSPRPV
     SGMERERKVS MRLHRGAPVN ISSSDLTGRQ DTSRMSTSQN SIPFEHHGK
//
